These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 20696778)

  • 1. Statin attenuates experimental anti-glomerular basement membrane glomerulonephritis together with the augmentation of alternatively activated macrophages.
    Fujita E; Shimizu A; Masuda Y; Kuwahara N; Arai T; Nagasaka S; Aki K; Mii A; Natori Y; Iino Y; Katayama Y; Fukuda Y
    Am J Pathol; 2010 Sep; 177(3):1143-54. PubMed ID: 20696778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ANG II receptor blockade enhances anti-inflammatory macrophages in anti-glomerular basement membrane glomerulonephritis.
    Aki K; Shimizu A; Masuda Y; Kuwahara N; Arai T; Ishikawa A; Fujita E; Mii A; Natori Y; Fukunaga Y; Fukuda Y
    Am J Physiol Renal Physiol; 2010 Apr; 298(4):F870-82. PubMed ID: 20071465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blockade of the c-Jun amino terminal kinase prevents crescent formation and halts established anti-GBM glomerulonephritis in the rat.
    Ma FY; Flanc RS; Tesch GH; Bennett BL; Friedman GC; Nikolic-Paterson DJ
    Lab Invest; 2009 Apr; 89(4):470-84. PubMed ID: 19188913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant human soluble thrombomodulin attenuates anti-glomerular basement membrane glomerulonephritis in Wistar-Kyoto rats through anti-inflammatory effects.
    Tachibana S; Iyoda M; Matsumoto K; Wada Y; Suzuki T; Iseri K; Kanazawa N; Shibata T
    Nephrol Dial Transplant; 2019 May; 34(5):774-782. PubMed ID: 29982644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atorvastatin attenuates murine anti-glomerular basement membrane glomerulonephritis.
    Eller P; Eller K; Wolf AM; Reinstadler SJ; Tagwerker A; Patsch JR; Mayer G; Rosenkranz AR
    Kidney Int; 2010 Mar; 77(5):428-35. PubMed ID: 20016464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Group 1 innate lymphoid cells are involved in the progression of experimental anti-glomerular basement membrane glomerulonephritis and are regulated by peroxisome proliferator-activated receptor α.
    Okabayashi Y; Nagasaka S; Kanzaki G; Tsuboi N; Yokoo T; Shimizu A
    Kidney Int; 2019 Oct; 96(4):942-956. PubMed ID: 31402171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Addition of angiotensin II type 1 receptor blocker to CCR2 antagonist markedly attenuates crescentic glomerulonephritis.
    Urushihara M; Ohashi N; Miyata K; Satou R; Acres OW; Kobori H
    Hypertension; 2011 Mar; 57(3):586-93. PubMed ID: 21282555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. c-fms blockade reverses glomerular macrophage infiltration and halts development of crescentic anti-GBM glomerulonephritis in the rat.
    Han Y; Ma FY; Tesch GH; Manthey CL; Nikolic-Paterson DJ
    Lab Invest; 2011 Jul; 91(7):978-91. PubMed ID: 21519331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-11 attenuates nephrotoxic nephritis in Wistar Kyoto rats.
    Lai PC; Cook HT; Smith J; Keith JC; Pusey CD; Tam FWK
    J Am Soc Nephrol; 2001 Nov; 12(11):2310-2320. PubMed ID: 11675407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atorvastatin enhances humoral immune responses but does not alter renal injury in experimental crescentic glomerulonephritis.
    Phoon RK; Kitching AR; Jones LK; Holdsworth SR
    Nephrology (Carlton); 2009 Oct; 14(7):650-7. PubMed ID: 19796023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin II type I receptor blockade suppresses glomerular renin-angiotensin system activation, oxidative stress, and progressive glomerular injury in rat anti-glomerular basement membrane glomerulonephritis.
    Kinoshita Y; Kondo S; Urushihara M; Suga K; Matsuura S; Takamatsu M; Shimizu M; Nishiyama A; Kawachi H; Kagami S
    Transl Res; 2011 Oct; 158(4):235-48. PubMed ID: 21925120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular endothelial growth factor165 resolves glomerular inflammation and accelerates glomerular capillary repair in rat anti-glomerular basement membrane glomerulonephritis.
    Shimizu A; Masuda Y; Mori T; Kitamura H; Ishizaki M; Sugisaki Y; Fukuda Y
    J Am Soc Nephrol; 2004 Oct; 15(10):2655-65. PubMed ID: 15466270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic effects of human mesenchymal stem cells in Wistar-Kyoto rats with anti-glomerular basement membrane glomerulonephritis.
    Suzuki T; Iyoda M; Shibata T; Ohtaki H; Matsumoto K; Shindo-Hirai Y; Kuno Y; Wada Y; Yamamoto Y; Kawaguchi M; Shioda S; Akizawa T
    PLoS One; 2013; 8(6):e67475. PubMed ID: 23826305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydroxymethylglutaryl coenzyme a reductase inhibitors down-regulate chemokines and chemokine receptors in patients with coronary artery disease.
    Waehre T; Damås JK; Gullestad L; Holm AM; Pedersen TR; Arnesen KE; Torsvik H; Frøland SS; Semb AG; Aukrust P
    J Am Coll Cardiol; 2003 May; 41(9):1460-7. PubMed ID: 12742282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-level laser therapy improves crescentic glomerulonephritis in rats.
    Yamato M; Kaneda A; Kataoka Y
    Lasers Med Sci; 2013 Jul; 28(4):1189-96. PubMed ID: 23139073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atorvastatin enhances interleukin-10 levels and improves cardiac function in rats after acute myocardial infarction.
    Stumpf C; Petzi S; Seybold K; Wasmeier G; Arnold M; Raaz D; Yilmaz A; Daniel WG; Garlichs CD
    Clin Sci (Lond); 2009 Jan; 116(1):45-52. PubMed ID: 18459941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic effect of all-trans retinoic acid on rats with anti-GBM antibody glomerulonephritis.
    Oseto S; Moriyama T; Kawada N; Nagatoya K; Takeji M; Ando A; Yamamoto T; Imai E; Hori M
    Kidney Int; 2003 Oct; 64(4):1241-52. PubMed ID: 12969142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of experimental crescentic glomerulonephritis by interleukin-10 gene transfer.
    El-Shemi AG; Fujinaka H; Matsuki A; Kamiie J; Kovalenko P; Qu Z; Bilim V; Nishimoto G; Yaoita E; Yoshida Y; Anegon I; Yamamoto T
    Kidney Int; 2004 Apr; 65(4):1280-9. PubMed ID: 15086467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-inflammatory and renal protective actions of stanniocalcin-1 in a model of anti-glomerular basement membrane glomerulonephritis.
    Huang L; Garcia G; Lou Y; Zhou Q; Truong LD; DiMattia G; Lan XR; Lan HY; Wang Y; Sheikh-Hamad D
    Am J Pathol; 2009 Apr; 174(4):1368-78. PubMed ID: 19246645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic effects and mechanism of conditioned media from human mesenchymal stem cells on anti-GBM glomerulonephritis in WKY rats.
    Iseri K; Iyoda M; Ohtaki H; Matsumoto K; Wada Y; Suzuki T; Yamamoto Y; Saito T; Hihara K; Tachibana S; Honda K; Shibata T
    Am J Physiol Renal Physiol; 2016 Jun; 310(11):F1182-91. PubMed ID: 27053690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.